Mass Drug Administration for Trachoma: How Long Is Not Long Enough?

BACKGROUND: Blinding trachoma is targeted for elimination by 2020 using the SAFE strategy (Surgery, Antibiotics, Facial cleanliness, and Environmental improvements). Annual mass drug administration (MDA) with azithromycin is a cornerstone of this strategy. If baseline prevalence of clinical signs of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jimenez, Violeta, Gelderblom, Huub C., Mann Flueckiger, Rebecca, Emerson, Paul M., Haddad, Danny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370651/
https://www.ncbi.nlm.nih.gov/pubmed/25799168
http://dx.doi.org/10.1371/journal.pntd.0003610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370651/
https://www.ncbi.nlm.nih.gov/pubmed/25799168
http://dx.doi.org/10.1371/journal.pntd.0003610

Ejemplares similares